Changing the Practice of Medicine
Popular
- CME/CE
Advancing Bispecific Antibodies Upstream in the Treatment Paradigm of Multiple Myeloma
0.25 credits
María-Victoria Mateos, MD, PhD
David Rubin, MD
Jennifer Geremia, PA-C
David Rubin, MD
Brooke Hodnick, PA-C, MPAS
Kimberly D. Orleck, PA-C
Jennifer Geremia, PA-C
David Rubin, MD
Brooke Hodnick, PA-C, MPAS
Jennifer Geremia, PA-C
Brooke Hodnick, PA-C, MPAS
David Rubin, MD
Kimberly D. Orleck, PA-C
Kimberly D. Orleck, PA-C
Jennifer Geremia, PA-C
CME/CE
- MinuteCE®
NSCLC Data Review: Efficacy and Safety Data for ON-State RAS Inhibitors
0.75 program creditsKathryn Arbour
Eileen M. O'Reilly, MD
Kathryn Arbour
Kevin J Harrington, PhD, FRCP, FRCR, FRSB
Christophe Le Tourneau, MD, PhD
- CME/CE
Breaking the Line: Moving Bispecific Antibodies Upstream in Treating Multiple Myeloma
0.25 creditsMaría-Victoria Mateos, MD, PhD
Pushpa Narayanaswami, MD, FAAN
A.J. Gelderblom, MD, PhD
Clinical Practice
- MinuteCE®
Early Approaches to RAS Targeting: Efficacy Signals and Known Limitations
0.75 program creditsKathryn Arbour
Eileen M. O'Reilly, MD
Kimberly D. Orleck, PA-C
Brooke Hodnick, PA-C, MPAS
- MinuteCE®
From Flare to Farewell: The IBD Care Playbook for Advanced Practice Providers
1.00 credit 9 episodesDavid Rubin, MD
Kimberly D. Orleck, PA-C
Jennifer Geremia, PA-C
Brooke Hodnick, PA-C, MPAS
- MinuteCE®
Applying the Evidence: TGCT Treatment Insights for Sports Medicine Physicians
1.00 program creditA.J. Gelderblom, MD, PhD
Chelsea Cole, MD
A.J. Gelderblom, MD, PhD
Michiel van de Sande, MD, PhD
Chelsea Cole, MD
A.J. Gelderblom, MD, PhD
Programs
Linda Stein Gold, MD
Bruce Strober, MD, PhD
- MinuteCE®
Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
1.00 program creditA.J. Gelderblom, MD, PhD
A.J. Gelderblom, MD, PhD
A.J. Gelderblom, MD, PhD
- MinuteCE®
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
1.00 program creditA.J. Gelderblom, MD, PhD
Michiel van de Sande, MD, PhD
Linda Stein Gold, MD
April W. Armstrong, MD, MPH